BIOPX
Price
$59.28
Change
-$1.10 (-1.82%)
Updated
Jun 23 closing price
Net Assets
2.05B
RGACX
Price
$82.24
Change
-$1.83 (-2.18%)
Updated
Jun 23 closing price
Net Assets
360.63B
Interact to see
Advertisement

BIOPX vs RGACX

BIOPX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
BIOPX vs. RGACX commentary
Jun 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOPX is a Hold and RGACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 361B vs. BIOPX (2.05B). BIOPX (0.00) and RGACX (0.00) have matching dividends . BIOPX was incepted earlier than RGACX: BIOPX (26 years) vs RGACX (24 years). BIOPX (1.31) is less costly to investors than RGACX (0.93). RGACX is a more actively managed with annual turnover of: 32.00 vs. BIOPX (30.00). RGACX has a lower initial minimum investment than BIOPX: RGACX (250) vs BIOPX (2000). BIOPX annual gain was more profitable for investors over the last year : 20.73 vs. RGACX (7.94). BIOPX return over 5 years is better than : 32.53 vs. RGACX (13.23).
BIOPXRGACXBIOPX / RGACX
Total Expense Ratio1.310.93141%
Annual Report Gross Expense Ratio1.310.93141%
Fund Existence26 years24 years-
Gain YTD9.7986.185158%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets2.05B361B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year20.737.94261%
Returns for 3 years87.1243.05202%
Returns for 5 years32.5313.23246%
Returns for 10 years282.45107.97262%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NFEAX18.78N/A
N/A
Columbia Large Cap Growth Opp A
FSPSX67.33N/A
N/A
Fidelity International Index
KMDIX34.41N/A
N/A
Keeley Gabelli Mid Cap Dividend I
SSAQX79.58N/A
N/A
State Street US Core Equity Fund
FEAIX32.12-0.19
-0.59%
First Eagle Rising Dividend Fund I